| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-20 | Woods Keith Chief Operating Officer | Sale | -10,220 | -1.62%620,055 | $49.57 | $506,651 | View SEC filing | |
| 2026-04-20 | Vaishnaw Akshay President of R&D | Sale | -12,246 | -1.91%630,542 | $49.57 | $607,089 | View SEC filing | |
| 2026-04-20 | Sinha Vikas Chief Financial Officer | Sale | -10,410 | -1.65%619,856 | $49.57 | $516,071 | View SEC filing | |
| 2026-04-20 | Hallal David Chief Executive Officer | Sale | -30,615 | -1.83%1,639,034 | $49.57 | $1,517,723 | View SEC filing | |
| 2026-02-25 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | -8,484 | -7.93%98,445 | $47.07 | $399,351 | View SEC filing | |
| 2026-02-19 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | -7,989 | -6.95%106,929 | $46.53 | $371,714 | View SEC filing | |
| 2026-02-19 | Parlavecchio Caryn CHRO | Sale | -9,035 | -5.07%169,087 | $46.53 | $420,382 | View SEC filing | |
| 2026-02-19 | Ho Junlin GENERAL COUNSEL | Sale | -9,580 | -3.81%241,545 | $46.53 | $445,740 | View SEC filing | |
| 2026-02-19 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale | -4,157 | -3.19%126,012 | $46.53 | $193,418 | View SEC filing | |
| 2026-01-23 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | -14,898 | -14.82%85,660 | $46.71 | $695,938 | View SEC filing | |
| 2026-01-21 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | -8,406 | -7.71%100,558 | $44.48 | $373,880 | View SEC filing | |
| 2026-01-21 | Parlavecchio Caryn CHRO | Sale | -6,600 | -4.25%148,864 | $44.48 | $293,553 | View SEC filing | |
| 2026-01-21 | Ho Junlin GENERAL COUNSEL | Sale | -8,016 | -3.60%214,553 | $44.48 | $356,533 | View SEC filing | |
| 2026-01-21 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale | -5,798 | -5.71%95,687 | $44.48 | $257,882 | View SEC filing | |
| 2026-01-16 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | -13,112 | -10.74%108,964 | $45.20 | $592,611 | View SEC filing | |
| 2026-01-15 | Sinha Vikas Chief Financial Officer | Sale | -16,755 | -2.79%583,245 | $42.70 | $715,439 | View SEC filing | |
| 2026-01-15 | Woods Keith Chief Operating Officer | Sale | -16,746 | -2.79%583,254 | $42.70 | $715,054 | View SEC filing | |
| 2026-01-15 | Vaishnaw Akshay President of R&D | Sale | -20,438 | -3.32%595,767 | $42.70 | $872,703 | View SEC filing | |
| 2026-01-15 | Hallal David Chief Executive Officer | Sale | -57,450 | -3.59%1,541,645 | $42.70 | $2,453,115 | View SEC filing | |
| 2025-12-18 | Peng Katie Director | Sale | -1,006 | -2.97%32,908 | $44.09 | $44,352 | View SEC filing | |
| 2025-12-16 | AKKARAJU SRINIVAS Director | Purchase | +29,599 | +5.91%530,038 | $39.92 | $1,181,634 | View SEC filing | |
| 2025-12-05 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | -136,462 | -55.60%108,964 | $45.21 | $6,169,788 | View SEC filing | |
| 2025-10-07 | AKKARAJU SRINIVAS Director | Purchase | +500,439 | +100.00%500,439 | $37.58 | $18,807,352 | View SEC filing | |
| 2025-09-24 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | -3,353 | -2.99%108,964 | $30.67 | $102,846 | View SEC filing | |
| 2025-09-17 | Peng Katie Director | Sale | -1,006 | -2.88%33,914 | $32.53 | $32,726 | View SEC filing |
1-25 of 109
